Cationic lipid-conjugated dexamethasone as a selective antitumor agent

European Journal of Medicinal Chemistry

Volumn 83, Issue , 2014, Pages 433-447

  Sau, Samaresh ^a   Banerjee, Rajkumar ^a,b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Apoptosis; Cationic lipid; Dexamethasone; Glucocorticoid receptor; Tumor

Indexed keywords

CARBON; CASPASE 3; DEXAMETHASONE DERIVATIVE; GLUCOCORTICOID RECEPTOR; JANUS KINASE 3; PROTEIN P53; STAT3 PROTEIN; VASCULOTROPIN RECEPTOR 2; DEXAMETHASONE; PROTEIN KINASE B; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; LIPID; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG SELECTIVITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CYTOTOXICITY; DRUG SYNTHESIS; ENZYME DEGRADATION; MOUSE; PROTEIN EXPRESSION; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; TUMOR CELL LINE; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DEXAMETHASONE; DOWN-REGULATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPIDS; MICE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84903710654     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.06.051     Document Type: Article

References (30)

1. J.D. Ashwell, F.W. Lu, and M.S. Vacchio Glucocorticoids in T cell development and function Annu. Rev. Immunol. 18 2000 309 345 (Pubitemid 30365383)
2. M. Reichardt, F. Tronche, S. Berger, C. Kellendonk, and G. Schutz New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting Adv. Pharmacol. 47 2000 1 21
3. L. Frego, and W. Davidson Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry Protein Sci. 15 2006 722 730
4. A. McMaster, and D.W. Ray Drug insight: selective agonists and antagonists of the glucocorticoid receptor Nat. Clin. Pract. Endocrinol. Metab. 4 2008 91 101 (Pubitemid 351156903)
5. M. Beato, P. Herrlich, and G. Schütz Steroid hormone receptors: many actors in search of a plot Cell 83 1995 851 857 (Pubitemid 26006527)
6. S. Roux, B. Térouanne, P. Balaguer, N. Jausons-Loffreda, M. Pons, Chambon, H. Gronemeyer, and J.C. Nicolas Mutation of isoleucine 747 by a threonine alters the ligand responsiveness of the human glucocorticoid receptor Mol. Endocrinol. 10 1996 1214 1226 (Pubitemid 26330954)
7. R. Kofler The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells Histochem. Cell Biol. 114 2000 1 7 (Pubitemid 30609850)
8. S. Sharma, and A. Lichtenstein Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors Blood 112 2008 1338 1345
9. P.J. Hesketh, and P.S. Altamira Aprepitant, dexamethasone, and palonosetron in the prevention of doxorubicin/cyclophosphamide-induced nausea and vomiting Support Care Cancer 20 2012 653 656
10. S.H. Shim, J.H. Hah, S.Y. Hwang, D.S. Heo, and M.W. Sung Dexamethasone treatment inhibits VEGF production via suppression of STAT3 in a head and neck cancer cell line Oncol. Rep. 23 2010 1139 1143
11. H. Ge, S. Ni, X. Wang, N. Xu, Y. Liu, X. Wang, L. Wang, D. Song, Y. Song, and C. Bai Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer PLoS One 7 2012 e51821
12. I. Herr, E. Ucur, K. Herzer, S. Okouoyo, R. Ridder, P.H. Krammer, M. von Knebel Doeberitz, and K.M. Debatin Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas Cancer Res. 63 2003 3112 3120 (Pubitemid 36735861)
13. A. Mukherjee, K.P. Narayan, K. Pal, J.M. Kumar, N. Rangaraj, S.V. Kalivendi, and R. Banerjee Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor Mol. Ther. 17 2009 623 631
14. K. Pal, S.K. Pore, S. Sinha, R. Janardhanan, D. Mukhopadhyay, and R. Banerjee Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics J. Med. Chem. 54 2011 2378 2390
15. S. Sinha, S. Roy, B.S. Reddy, K. Pal, G. Sudhakar, S. Iyer, S. Dutta, E. Wang, P.K. Vohra, K.R. Roy, P. Reddanna, D. Mukhopadhyay, and R. Banerjee A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis Mol. Cancer Res. 9 2011 364 374
16. P.R. Muktapurama, R.K. Gara, K. Sharma, C. Rohit, K. Srinivas, D.P. Mishra, and B.S. Reddy Anticancer siRNA delivery by new anticancer molecule: a novel combination strategy for cancer cell killing Eur. J. Med. Chem. 56 2012 400 408
17. H. Lin, W.M. Abida, R.T. Sauer, and V.W. Cornish Dexamethasone- methotrexate: An efficient chemical inducer of protein dimerization in vivo J. Am. Chem. Soc. 122 2000 4247 4248 (Pubitemid 30304874)
18. B. Giuseppe, A.T. Deborah, M.S. Jason, C. Louis, M. Lucas, D.J.P. Andrew, and V.M. Tom MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance Curr. Drug Targets 15 2014 114 123
19. P. Pratheeshkumar, A. Budhraja, Y.O. Son, X. Wang, Z. Zhang, S. Ding, L. Wang, A. Hitron, J.C. Lee, M. Xu, G. Chen, J. Luo, and X. Shi Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K signaling pathways PLoS One 7 2012 e47516
20. S. Saeed, B.D. Mohammad, M. Gholamreza, T. Mohammadreza, Role of Caspases, Bax and Bcl-2 in chrysin-induced apoptosis in the A549 human lung adenocarcinoma epithelial cells, Anti Cancer Agents Med. Chem. http://dx.doi.org/10.2174/1871520614666140209144042.
21. E.H. Cheng, D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedi, K. Ueno, and J.M. Hardwick Conversion of Bcl-2 to a Bax-like death effector by caspases Science 278 1997 1966 1968 (Pubitemid 28013242)
22. Z. Gao, Y. Tian, J. Wang, Q. Yin, H. Wu, Y.M. Li, and X. Jiang Dimeric Smac/Diablo peptide directly relieves caspase-3 inhibition by XIAP dynamic and cooperative regulation of XIAP by Smac/Diablo J. Biol. Chem. 282 2007 30718 30727 (Pubitemid 350035215)
23. L. Ghibelli, and M. Diederich Multistep and multitask Bax activation Mitochondrion 10 2010 604 613
24. E.S. Kandel, and N. Hay The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB Exp. Cell Res. 253 1999 210 229
25. J.R. Testa, and A. Bellacosa Akt plays a central role in tumorigenesis Proc. Natl. Acad. Sci. U. S. A. 98 2001 10983 10985 (Pubitemid 32928669)
26. S.R. Choudhari, M.A. Khan, G. Harris, D. Picker, G.S. Jacob, T. Block, and K. Shailubhai Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod Mol. Cancer Ther. 6 2007 112 121 (Pubitemid 46206673)
27. A.J. Levine p53 the cellular gate keeper for growth and division Cell 88 1997 323 331 (Pubitemid 27131374)
28. A.J. Levine, J. Momand, and C.A. Finlay The p53 tumour suppressor gene Nature 351 1991 453 456 (Pubitemid 21896613)
29. R. Srinivas, A. Garu, G. Moku, S.B. Agawane, and A. Chaudhuri A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups Biomaterials 33 2012 662 6229
30. S.K. Pore, A. Choudhary, B. Rathore, A. Ganguly, P. Sujitha, C.G. Kumar, S.B. Agawane, J.M. Kumar, V. Scaria, B. Pillai, and R. Banerjee Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect Biomaterials 34 2013 6804 6817